๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinical study of intrapleural administration of pirarubicin (THP-ADM) for treatment of malignant pleural effusion secondary to lung cancer

Book ID
122565625
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
148 KB
Volume
11
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Intrapleural talc for the treatment of m
Intrapleural talc for the treatment of malignant pleural effusions secondary to breast cancer
โœ Ribas C. Milanez; Francisco S. Vargas; Luiz B. Filomeno; Lisete R. Teixeira; Ang ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 448 KB ๐Ÿ‘ 2 views

Background. The management of malignant pleural effusions secondary to breast cancer is a difficult problem. In the 1980s tetracycline was probably the most commonly used sclerosing agent, but parenteral tetracycline is no longer available. Therefore, it is important to evaluate alternative sclerosi

A comparative trial of LC9018 plus doxor
A comparative trial of LC9018 plus doxorubicin and doxorubicin alone for the treatment of malignant pleural effusion secondary to lung cancer
โœ Tomiya Masuno; Susumu Kishimoto; Takeshi Ogura; Takeshi Honma; Hisanobu Niitani; ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 565 KB

The efficacy and safety of intrapleural LC9018 (Yakult Co. Ltd., Tokyo, Japan) with or without doxorubicin (Adriamycin; Adria Laboratories, Columbus, OH) were evaluated in a randomized, controlled trial performed in 95 patients with malignant pleural effusions secondary to lung cancer. Seventy-six p